Diagnostic Approach for Elevated Alkaline Phosphatase

Initial Evaluation

The American College of Physicians recommends measuring bone-specific alkaline phosphatase (B-ALP) isoenzymes to determine the tissue source of elevated alkaline phosphatase, as this distinguishes between hepatobiliary and bone etiologies 1
The European Association for the Study of the Liver suggests obtaining liver function tests, including bilirubin, AST, ALT, and GGT, to assess for hepatobiliary disease 2
The National Osteoporosis Foundation recommends checking serum calcium, phosphate, and PTH to evaluate for metabolic bone disorders 1
The Endocrine Society suggests measuring 25-hydroxyvitamin D to assess for vitamin D deficiency 1

The American Gastroenterological Association recommends obtaining MRCP to evaluate for biliary obstruction or primary sclerosing cholangitis if the ALP elevation is hepatic in origin with elevated bilirubin or transaminases 2
The National Comprehensive Cancer Network suggests obtaining abdominal imaging with CT or MRI if elevated ALP is accompanied by abnormal liver function tests or abdominal symptoms 3

The American College of Radiology recommends obtaining a bone scan as the primary imaging modality if B-ALP is elevated or bone pain is present, as bone pain combined with elevated ALP increases the likelihood of bone metastases 1
The National Kidney Foundation suggests monitoring calcium, phosphate, PTH, and ALP every 12 months in CKD stages 4-5, or more frequently if PTH is elevated 1

The American Association for the Study of Liver Diseases recommends considering MRCP to evaluate for coincidental primary sclerosing cholangitis in patients with autoimmune hepatitis who have elevated ALP that does not normalize rapidly with immunosuppressive treatment 2
The National Comprehensive Cancer Network suggests that bone scan is indicated for patients with known malignancy (renal, breast, bladder, prostate) who present with elevated ALP or bone pain 4, 5, 3